FGF-21 Antibodies

Santa Cruz Biotechnology delivers a wide array of FGF-21 monoclonal antibodies for research focused on understanding Fibroblast Growth Factor 21. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Fibroblast Growth Factor 21 functions as a key regulator of glucose and lipid metabolism, playing a significant role in energy homeostasis and insulin sensitivity. Research has shown that FGF-21 is particularly relevant in metabolic disorders, such as obesity and type 2 diabetes, making it an important target for therapeutic interventions. Understanding FGF-21 signaling pathways continues to reveal new possibilities for treating metabolic diseases. Researchers worldwide are uncovering novel functions of FGF-21 in various physiological processes. Recent studies have highlighted FGF-21's involvement in cellular stress responses and tissue repair mechanisms. Ongoing investigations of FGF-21 are expanding knowledge about metabolic regulation and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of FGF-21's role in human health and disease.